AtriCure | ATRC - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.06B 69M 2026-03
Artivion USD 448.23M 9.54M 2025-12
AtriCure USD 491.69M 242K 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 25.86B 1.63B 2026-03
Cooper Companies USD 8.36B 124.7M 2025-12
Dexcom USD 2.96B 210.9M 2026-03
Edwards Lifesciences USD 10.34B 132.6M 2025-12
Globus Medical USD 4.57B 174.42M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intuitive Surgical USD 17.47B 349.5M 2026-03
J&J USD 81.19B 358M 2026-03
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.63B 42.42M 2026-03
ResMed USD 6.49B 171.03M 2026-03
Stryker USD 22.42B 635M 2025-12
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03